Hawaii Pacific Neuroscience — Honolulu, Hawaii

Hawaii Pacific Neuroscience is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Hawaii Pacific Neuroscience has participated in 59 clinical trials with 26 currently active.

Therapeutic areas: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Epilepsy, Chronic Migraine.

Sponsors: Takeda, Engage Therapeutics, Inc., Merz Therapeutics GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Honolulu

Browse all research sites in Hawaii · View every site in Honolulu

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hawaii Pacific Neuroscience?

Hawaii Pacific Neuroscience has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hawaii Pacific Neuroscience conducted?

Hawaii Pacific Neuroscience has 59 clinical trials on record, with 26 currently active. Their work covers Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Epilepsy, Chronic Migraine.

Is Hawaii Pacific Neuroscience accredited by Crixeo Clinical Trials?

Hawaii Pacific Neuroscience has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hawaii Pacific Neuroscience?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.